Patrick McCall
Director of Finance/CFO presso IN8BIO, INC.
Patrimonio netto: 31 571 $ in data 31/03/2024
Profilo
Patrick McCall is currently the Chief Financial Officer & Secretary at IN8bio, Inc. Prior to his current position, he worked as the Controller at Catalyst Biosciences, Inc. and as the Vice President-Finance at Turnstone Biologics Corp.
from 2018 to 2021.
Mr. McCall completed his undergraduate degree at Drexel University and holds an MBA from Cornell University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IN8BIO, INC.
0.06% | 07/02/2024 | 26 755 ( 0.06% ) | 31 571 $ | 31/03/2024 |
Posizioni attive di Patrick McCall
| Società | Posizione | Inizio |
|---|---|---|
| IN8BIO, INC. | Director of Finance/CFO | 08/02/2021 |
Precedenti posizioni note di Patrick McCall
| Società | Posizione | Fine |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Director of Finance/CFO | 01/02/2021 |
| CATALYST BIOSCIENCES | Comptroller/Controller/Auditor | - |
Formazione di Patrick McCall
| Drexel University | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IN8BIO, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Aziende private | 1 |
|---|---|
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Patrick McCall
